Evidence map›Paper›PMID 33140398›Full record

SynthesisCardiology journal2021

Systematic review and meta-analysis appraising efficacy and safety of adrenaline for adult cardiopulmonary resuscitation.

Kobi Ludwin, Kamil Safiejko, Jacek Smereka, Klaudiusz Nadolny, Maciej Cyran, Ruslan Yakubtsevich, Milosz J Jaguszewski, Krzysztof J Filipiak, Lukasz Szarpak, Antonio Rodríguez-Núñez

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cardiology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Cardiac Arrest: Can Technology Be the Solution?Journal of clinical medicine · 2025
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 4 countries.

Kobi LudwinPolish Society of Disaster Medicine, Warsaw, Poland.ORCID 0000-0001-8840-4912
Kamil SafiejkoBialystok Oncology Center, Bialystok, Poland.
Jacek SmerekaPolish Society of Disaster Medicine, Warsaw, Poland.ORCID 0000-0002-1427-4796
Klaudiusz NadolnyDepartment of Emergency Medical Service, Higher School of Strategic Planning in Dabrowa Gornicza, Dabrowa Gornicza, Poland.ORCID 0000-0003-0355-241X
Maciej CyranMaria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland.ORCID 0000-0002-7194-5445
Ruslan YakubtsevichDepartment of Anesthesiology and Intensive Care Grodno State Medical University, Grodno, Belarus.ORCID 0000-0002-8699-8216
Milosz J JaguszewskiFirst Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
Krzysztof J FilipiakFirst Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-6563-0877
Lukasz SzarpakBialystok Oncology Center, Bialystok, Poland. lukasz.szarpak@gmail.com.ORCID 0000-0002-0973-5455
Antonio Rodríguez-NúñezPediatric Intensive Care Unit, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0003-3414-2771
Gdańsk Medical University · PLGrodno State Medical University · BYKatowice School of Technology · PLMedical University of Warsaw · PLUczelnia Warszawska im. Marii Skłodowskiej-Curie · PLUniversidade de Santiago de Compostela · ESUniversity of Białystok · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a beneficial effect of adrenaline during adult cardiopulmonary resuscitation (CPR) from cardiac arrest but there is also uncertainty about its safety and effectiveness. The aim of this study was to evaluate the use of adrenaline versus non-adrenaline CPR.

methodsPubMed, ScienceDirect, Embase, CENTRAL (Cochrane Central Register of Controlled Trials) and Google Scholar databases were searched from their inception up to 1st July 2020. Two reviewers independently assessed eligibility and risk of bias, with conflicts resolved by a third reviewer. Risk ratio (RR) or mean difference of groups were calculated using fixed or random-effect models.

resultsNineteen trials were identified. The use of adrenaline during CPR was associated with a significantly higher percentage of return of spontaneous circulation (ROSC) compared to non-adrenaline treatment (20.9% vs. 5.9%; RR = 1.87; 95% confidence interval [CI] 1.37-2.55; p < 0.001). The use of adrenaline in CPR was associated with ROSC at 19.4% and for non-adrenaline treatment - 4.3% (RR = 3.23; 95% CI 1.89-5.53; p < 0.001). Survival to discharge (or 30-day survival) when using adrenaline was 6.8% compared to non-adrenaline treatment (5.5%; RR = 0.99; 95% CI 0.76-1.30; p = 0.97). However, the use of adrenaline was associated with a worse neurological outcome (1.6% vs. 2.2%; RR = 0.57; 95% CI 0.42-0.78; p < 0.001).

conclusionsThis review suggests that resuscitation with adrenaline is associated with the ROSC and survival to hospital discharge, but no higher effectiveness was observed at discharge with favorable neurological outcome. The analysis showed higher effectiveness of ROSC and survival to hospital discharge in non-shockable rhythms. But more multicenter randomized controlled trials are needed in the future.

Indexed as

Cardiopulmonary ResuscitationEpinephrineOut-of-Hospital Cardiac ArrestHumansMulticenter Studies as TopicPatient DischargeReturn of Spontaneous CirculationEpinephrineadrenalinecardiac arrestcardiopulmonary resuscitationepinephrinemeta-analysisoutcomereturn of spontaneous circulationsystematic review

Identifiers

PMID33140398
PMCPMC8078950
OpenAlexW3094124063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.